In summary, in pregnant women higher plasma kisspeptin levels are associated with enhanced insulin secretion, particularly after oral glucose load, and lower levels of plasma kisspeptin are associated with diagnosis of GDM. This evidence concerns the gene KISS1 and gestational diabetes.